AN2 Therapeutics (ANTX) announced a collaboration agreement with GSK (GSK) to develop new therapies for tuberculosis. As part of this effort, the Gates Foundation will provide a third year of funding to support AN2’s work within the collaboration.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANTX: